Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Hugh Glimcher Auchincloss, M.D.

Concepts (487)

Back to Profile

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name	Number of Publications	Most Recent Publication	Publications by All Authors	Concept Score	Why?
Transplantation, Heterologous	24	2004	2393	1.400	Why?
Graft Rejection	51	2011	4492	1.160	Why?
Skin Transplantation	27	2011	1096	1.080	Why?
Tracheostomy	2	2021	430	1.070	Why?
Carcinoma, Non-Small-Cell Lung	7	2024	5432	0.940	Why?
Trachea	2	2024	1095	0.880	Why?
Transplantation Immunology	10	2004	537	0.820	Why?
Pericardial Effusion	1	2023	246	0.740	Why?
Multiple Pulmonary Nodules	1	2023	175	0.740	Why?
Lung Neoplasms	8	2024	13586	0.670	Why?
Thoracic Outlet Syndrome	1	2021	97	0.640	Why?
Pleural Neoplasms	1	2023	612	0.610	Why?
Histocompatibility Antigens Class II	16	2002	1441	0.600	Why?
Radiosurgery	2	2024	1330	0.570	Why?
Islets of Langerhans Transplantation	12	2008	748	0.560	Why?
Graft Survival	32	2011	3887	0.540	Why?
Immune Tolerance	16	2010	2323	0.540	Why?
CD4-Positive T-Lymphocytes	17	2005	4415	0.480	Why?
Antigens, Differentiation, T-Lymphocyte	9	1992	897	0.480	Why?
T-Lymphocytes	23	2011	10266	0.470	Why?
Tomography, Optical Coherence	5	2024	2957	0.420	Why?
Idiopathic Pulmonary Fibrosis	3	2024	521	0.410	Why?
Lymphocyte Depletion	9	2004	605	0.400	Why?
Allergy and Immunology	2	2011	175	0.400	Why?
Vascular Surgical Procedures	1	2021	1506	0.390	Why?
Tracheal Diseases	1	2012	118	0.390	Why?
Bronchoscopy	4	2024	914	0.390	Why?
Thoracic Surgical Procedures	1	2015	350	0.380	Why?
Lymphatic Diseases	1	2012	319	0.370	Why?
Pneumonectomy	5	2024	1156	0.360	Why?
Heart Transplantation	14	2011	3301	0.360	Why?
T-Lymphocytes, Helper-Inducer	7	1997	977	0.350	Why?
Histocompatibility Antigens Class I	8	1999	1361	0.350	Why?
Lymphocyte Activation	9	2011	5505	0.340	Why?
Mice, Inbred BALB C	34	2011	6231	0.340	Why?
Cell Transplantation	6	2000	475	0.320	Why?
Isoantigens	6	2001	562	0.320	Why?
Transplantation Tolerance	3	2004	633	0.300	Why?
Organ Transplantation	4	1999	1176	0.290	Why?
Diabetes Mellitus, Type 1	15	2008	3447	0.280	Why?
Transplantation, Homologous	19	2011	4833	0.270	Why?
Major Histocompatibility Complex	6	2001	877	0.270	Why?
Isoantibodies	8	2006	681	0.260	Why?
Genes, MHC Class II	5	2004	433	0.250	Why?
Antigen Presentation	4	2004	1251	0.240	Why?
Disease Management	1	2015	2536	0.240	Why?
Lung Diseases, Interstitial	2	2024	940	0.230	Why?
Neurosurgical Procedures	1	2015	2076	0.230	Why?
Graft Enhancement, Immunologic	3	2004	58	0.230	Why?
Neoplasm Staging	6	2023	11244	0.230	Why?
Animals	91	2011	169246	0.220	Why?
Antibodies, Monoclonal	20	2005	9263	0.220	Why?
Kaplan-Meier Estimate	2	2024	6526	0.210	Why?
Immunosuppressive Agents	10	2006	4206	0.210	Why?
Immunoconjugates	3	2001	975	0.210	Why?
Antigens, Differentiation	5	2005	921	0.210	Why?
Cyclosporins	4	1990	216	0.200	Why?
Antigens, Surface	4	2003	1617	0.200	Why?
Nuclear Transfer Techniques	1	2002	61	0.200	Why?
Kidney Transplantation	18	2004	4262	0.190	Why?
Mice	63	2011	82029	0.190	Why?
Subclavian Vein	1	2021	57	0.180	Why?
Mice, Inbred C57BL	34	2007	22379	0.180	Why?
Mice, Mutant Strains	11	2005	1754	0.180	Why?
T-Lymphocyte Subsets	5	2003	1815	0.180	Why?
Antigen-Presenting Cells	7	2001	960	0.180	Why?
Subclavian Artery	1	2021	138	0.170	Why?
Antilymphocyte Serum	7	2003	492	0.170	Why?
Lymphocyte Cooperation	2	1996	112	0.170	Why?
Humans	82	2024	768166	0.160	Why?
CD8-Positive T-Lymphocytes	10	2005	4648	0.160	Why?
Receptors, Tumor Necrosis Factor	2	2001	587	0.160	Why?
Insurance Coverage	3	2016	1946	0.160	Why?
Mice, Inbred Strains	10	2002	1765	0.160	Why?
Dilatation	1	2021	311	0.160	Why?
Ribs	1	2021	259	0.160	Why?
Brachial Plexus	1	2021	171	0.160	Why?
Immunity, Cellular	5	1999	1561	0.160	Why?
Muscle Fibers, Skeletal	1	2002	553	0.160	Why?
Clavicle	1	2021	224	0.150	Why?
Small Cell Lung Carcinoma	1	2023	454	0.150	Why?
T-Lymphocytes, Cytotoxic	5	2005	1801	0.150	Why?
Histocompatibility Antigens	5	1996	479	0.150	Why?
Thorax	1	2021	557	0.150	Why?
Autoimmunity	4	2007	1361	0.140	Why?
Swine	14	2004	5995	0.140	Why?
Genes, MHC Class I	3	1997	235	0.140	Why?
Health Care Reform	3	2016	1256	0.140	Why?
CD40 Ligand	5	2006	528	0.130	Why?
Pancreas Transplantation	7	2003	193	0.130	Why?
History, 20th Century	4	2011	2766	0.130	Why?
Spleen	5	2004	2295	0.120	Why?
Healthcare Disparities	3	2016	3415	0.120	Why?
Robotics	1	2022	812	0.120	Why?
Insurance, Health	3	2016	2517	0.120	Why?
Cholecystitis, Acute	1	2015	81	0.120	Why?
Host vs Graft Reaction	1	1994	13	0.120	Why?
Bone Marrow Transplantation	7	2001	2709	0.120	Why?
Aftercare	1	2020	916	0.120	Why?
Mice, Inbred NOD	8	2008	1837	0.120	Why?
Antigens, CD	9	2005	4035	0.110	Why?
Cytotoxicity, Immunologic	6	1993	1353	0.110	Why?
Swine, Miniature	7	2004	965	0.110	Why?
Myocytes, Cardiac	1	2002	1681	0.110	Why?
Resource Allocation	2	1994	354	0.110	Why?
Receptors, Chemokine	3	2006	652	0.110	Why?
Streptozocin	2	2003	190	0.110	Why?
Radiation Chimera	3	1988	216	0.110	Why?
Cholecystectomy	1	2015	408	0.100	Why?
Antibody-Dependent Cell Cytotoxicity	2	1996	306	0.100	Why?
Thymectomy	5	1994	200	0.100	Why?
Cyclosporine	5	2004	777	0.100	Why?
Thoracic Surgery	1	2019	727	0.100	Why?
Diabetes Mellitus, Experimental	3	2003	1124	0.100	Why?
Tissue Engineering	1	2002	1893	0.100	Why?
Islets of Langerhans	4	2008	1351	0.100	Why?
Antigens, Heterophile	1	1992	71	0.100	Why?
United States Food and Drug Administration	1	1999	1673	0.090	Why?
Research	1	1999	1979	0.090	Why?
Macaca fascicularis	6	2006	912	0.090	Why?
Venous Thromboembolism	1	2024	1883	0.090	Why?
Species Specificity	8	2002	2415	0.090	Why?
Liver Transplantation	5	1996	2401	0.080	Why?
Immunoglobulin Idiotypes	4	1983	201	0.080	Why?
NFATC Transcription Factors	1	2011	393	0.080	Why?
Models, Immunological	4	2002	518	0.080	Why?
Tissue Donors	6	2004	2381	0.080	Why?
Comorbidity	1	2024	10590	0.080	Why?
Antibodies	5	2007	2421	0.080	Why?
Health Care Rationing	1	1992	435	0.080	Why?
Bioethics	2	2000	118	0.080	Why?
Mice, Inbred C3H	5	1993	915	0.080	Why?
Government Programs	1	2010	278	0.080	Why?
Immune System Diseases	1	2010	253	0.080	Why?
Ethics, Medical	3	2000	785	0.080	Why?
Adoptive Transfer	4	2005	825	0.070	Why?
Mice, Inbred A	4	1998	245	0.070	Why?
Antibodies, Anti-Idiotypic	4	1983	355	0.070	Why?
alpha 1-Antitrypsin	1	2008	169	0.070	Why?
Histocompatibility Testing	5	2002	716	0.070	Why?
Health Status Disparities	2	2016	1885	0.070	Why?
Transplantation	2	2004	221	0.070	Why?
Zoonoses	2	2000	180	0.070	Why?
Mice, Knockout	10	2011	14488	0.070	Why?
Integrin beta3	1	2007	120	0.070	Why?
Primates	2	1999	520	0.070	Why?
Retrospective Studies	9	2024	81762	0.070	Why?
Autoantigens	2	2002	890	0.070	Why?
Crosses, Genetic	4	1995	752	0.070	Why?
Th1 Cells	4	2011	1042	0.070	Why?
Th2 Cells	4	2011	1078	0.070	Why?
Interleukin-2	2	2007	1895	0.070	Why?
Patient Protection and Affordable Care Act	1	2016	1188	0.060	Why?
Cytokines	7	2007	7453	0.060	Why?
Postoperative Complications	4	2024	15832	0.060	Why?
Budgets	1	2007	232	0.060	Why?
H-2 Antigens	3	1998	359	0.060	Why?
Transplantation, Heterotopic	1	2005	175	0.060	Why?
Male	39	2024	364719	0.060	Why?
Peripheral Arterial Disease	1	2016	1304	0.060	Why?
Fetal Tissue Transplantation	1	2004	139	0.060	Why?
T-Lymphocytes, Regulatory	4	2004	3114	0.060	Why?
Monocyte Chemoattractant Proteins	1	2004	48	0.060	Why?
Massachusetts	5	2019	8890	0.060	Why?
Insulin-Secreting Cells	2	2008	899	0.060	Why?
Bone Marrow	3	1993	2935	0.060	Why?
B-Lymphocytes	2	1996	4793	0.060	Why?
Cardiac Surgical Procedures	1	2019	3683	0.050	Why?
C-Peptide	4	2008	443	0.050	Why?
Clinical Competence	1	2019	4858	0.050	Why?
beta 2-Microglobulin	2	1995	330	0.050	Why?
Immunologic Memory	3	2005	1377	0.050	Why?
Prognosis	1	2023	30010	0.050	Why?
Cloning, Organism	1	2002	50	0.050	Why?
Self Tolerance	1	2002	122	0.050	Why?
Rabbits	6	1991	4772	0.050	Why?
Mice, SCID	2	1998	2627	0.050	Why?
Cell Adhesion Molecules	3	1993	1613	0.050	Why?
Female	37	2024	397192	0.050	Why?
Mice, Transgenic	5	2007	9561	0.050	Why?
History, 19th Century	1	2004	714	0.050	Why?
Health Services Accessibility	2	2016	5520	0.050	Why?
Down-Regulation	2	2005	2937	0.050	Why?
Patient Selection	2	1994	4260	0.050	Why?
Kidney	6	2003	7064	0.050	Why?
Polyglycolic Acid	1	2002	408	0.050	Why?
Lung	3	2024	10099	0.040	Why?
Thymus Gland	4	2001	1266	0.040	Why?
Acute Disease	6	2005	7243	0.040	Why?
Middle Aged	20	2024	223492	0.040	Why?
Tacrolimus	1	2004	750	0.040	Why?
Coated Materials, Biocompatible	1	2002	311	0.040	Why?
Receptors, CCR5	1	2002	491	0.040	Why?
Intraoperative Care	1	2003	770	0.040	Why?
Health Policy	1	1992	2698	0.040	Why?
Antibodies, Blocking	3	2005	250	0.040	Why?
Killer Cells, Natural	3	2005	2211	0.040	Why?
Transplantation Chimera	2	1999	594	0.040	Why?
Reperfusion Injury	1	2006	1039	0.040	Why?
Tissue and Organ Procurement	4	1994	986	0.040	Why?
Thoracic Surgery, Video-Assisted	1	2022	297	0.040	Why?
Membrane Glycoproteins	4	2005	3711	0.040	Why?
Retroviridae Infections	1	1999	148	0.040	Why?
Clone Cells	1	2002	1670	0.040	Why?
Severity of Illness Index	2	2016	15948	0.040	Why?
Internship and Residency	1	2019	5953	0.040	Why?
Lymphocyte Culture Test, Mixed	4	2002	510	0.040	Why?
Epitopes	3	1995	2528	0.040	Why?
Mycophenolic Acid	1	2000	348	0.040	Why?
Legislation, Medical	1	1998	99	0.040	Why?
Genes	1	1981	1824	0.040	Why?
Aged	9	2024	171504	0.040	Why?
Steroids	2	2000	938	0.040	Why?
Diagnosis, Differential	1	2012	13014	0.040	Why?
Cells, Cultured	4	2001	19015	0.040	Why?
Insulin	6	2008	6607	0.040	Why?
Immunoglobulin G	5	2000	4568	0.040	Why?
Transplantation, Autologous	1	2002	2120	0.030	Why?
Gene Transfer Techniques	1	2002	1207	0.030	Why?
Postoperative Care	1	2003	1480	0.030	Why?
Cattle	1	2002	3819	0.030	Why?
Portacaval Shunt, Surgical	1	1996	46	0.030	Why?
Membrane Proteins	2	2005	7876	0.030	Why?
Recombinant Fusion Proteins	2	1998	3740	0.030	Why?
Signal Transduction	5	2008	23645	0.030	Why?
Genetic Linkage	1	1981	2342	0.030	Why?
Hospitals, General	1	2001	809	0.030	Why?
Kidney Diseases	2	2006	2100	0.030	Why?
Solubility	1	1998	1083	0.030	Why?
Antigens	1	1981	1442	0.030	Why?
Receptors, Tumor Necrosis Factor, Type II	1	1998	348	0.030	Why?
Models, Animal	1	2002	2120	0.030	Why?
Immunoglobulin Fc Fragments	1	1998	287	0.030	Why?
Flow Cytometry	4	1996	5902	0.030	Why?
Retroviridae	1	1998	846	0.030	Why?
Muromonab-CD3	2	1994	104	0.030	Why?
Clinical Trials as Topic	2	2010	8054	0.030	Why?
Fibrosis	1	2022	2080	0.030	Why?
National Institutes of Health (U.S.)	2	2010	794	0.030	Why?
Cell Movement	1	2007	5210	0.030	Why?
Tissue Survival	1	1995	120	0.030	Why?
Portal Vein	2	2008	435	0.030	Why?
Chemotherapy, Adjuvant	1	2023	3556	0.030	Why?
Boston	3	2004	9374	0.030	Why?
Lymphocyte Subsets	1	1995	313	0.030	Why?
Clonal Deletion	1	1994	75	0.030	Why?
Adult	24	2019	223646	0.030	Why?
Time Factors	9	2008	40218	0.030	Why?
Pancreas	3	2006	1700	0.030	Why?
Rodentia	1	1995	262	0.030	Why?
Chromosome Mapping	1	1981	4620	0.030	Why?
Cell Differentiation	2	2008	11669	0.030	Why?
Clonal Anergy	1	1994	169	0.030	Why?
Immunoglobulin M	3	1989	1528	0.030	Why?
Mastectomy, Radical	2	1965	19	0.030	Why?
Hepatitis C	1	2003	1595	0.030	Why?
Transplantation, Isogeneic	2	2002	249	0.030	Why?
Models, Biological	2	2002	9495	0.030	Why?
Risk Adjustment	1	2016	599	0.020	Why?
Pulmonary Embolism	2	2024	2599	0.020	Why?
Aged, 80 and over	2	2019	59629	0.020	Why?
ATP-Binding Cassette Transporters	1	1995	567	0.020	Why?
Antigen-Antibody Reactions	2	1982	342	0.020	Why?
Treatment Outcome	5	2003	65371	0.020	Why?
Rats, Inbred WKY	1	1991	150	0.020	Why?
Rats, Inbred SHR	1	1991	186	0.020	Why?
Haplotypes	1	1998	2722	0.020	Why?
Glucose Tolerance Test	2	2006	1183	0.020	Why?
Biomedical Research	1	2007	3463	0.020	Why?
Combined Modality Therapy	1	2023	8542	0.020	Why?
Inflammation	2	2008	10873	0.020	Why?
Cadaver	4	2003	1363	0.020	Why?
United States	5	2023	73039	0.020	Why?
Intercellular Adhesion Molecule-1	2	1993	1134	0.020	Why?
Haplorhini	1	1991	523	0.020	Why?
Health Planning	1	1992	233	0.020	Why?
Life Support Care	1	1992	226	0.020	Why?
Ciprofloxacin	1	1992	313	0.020	Why?
Autoimmune Diseases	1	2002	2257	0.020	Why?
Federal Government	1	1992	266	0.020	Why?
Tumor Necrosis Factor-alpha	1	2001	4352	0.020	Why?
Antiviral Agents	1	2003	3073	0.020	Why?
Tumor Cells, Cultured	1	1998	6124	0.020	Why?
Transfection	1	1998	5755	0.020	Why?
Sirolimus	2	2007	1540	0.020	Why?
Gene Expression	1	2002	7598	0.020	Why?
Dose-Response Relationship, Immunologic	1	1989	361	0.020	Why?
Fluconazole	1	1989	156	0.020	Why?
New England	1	1992	1058	0.020	Why?
Lymphokines	1	1992	924	0.020	Why?
Chemokines	2	2004	963	0.020	Why?
Antibody Formation	2	1991	1393	0.020	Why?
Reoperation	3	1996	4329	0.020	Why?
Autopsy	2	2008	1011	0.020	Why?
Urinary Tract Infections	2	1992	804	0.020	Why?
Risk Assessment	2	2024	24315	0.020	Why?
Proportional Hazards Models	1	2022	12543	0.020	Why?
Skin	2	1994	4503	0.020	Why?
Interleukin-4	1	2011	1156	0.020	Why?
Cytomegalovirus	1	1992	753	0.020	Why?
Follow-Up Studies	6	2019	39348	0.020	Why?
Waiting Lists	1	1992	779	0.020	Why?
Integrin alpha4beta1	1	2007	119	0.020	Why?
Interleukin-15	1	2007	186	0.020	Why?
Blood Glucose	4	2006	6430	0.020	Why?
Case-Control Studies	1	2024	22291	0.020	Why?
Health Care Surveys	1	2013	2434	0.020	Why?
Mycoses	1	1989	386	0.020	Why?
Kidney Pelvis	1	1987	191	0.020	Why?
Binding Sites, Antibody	2	1983	340	0.020	Why?
Risk Factors	4	2024	74944	0.020	Why?
Creatinine	4	1996	1918	0.020	Why?
Linear Models	1	2016	5884	0.020	Why?
Lymphocyte Function-Associated Antigen-1	1	2007	381	0.020	Why?
Prospective Studies	4	2021	54926	0.020	Why?
Lymph Nodes	2	2008	3474	0.020	Why?
Receptors, Immunologic	1	1992	1418	0.020	Why?
Sutures	1	1987	282	0.020	Why?
Pancreatectomy	2	2006	825	0.020	Why?
Cytomegalovirus Infections	1	1992	837	0.020	Why?
Azathioprine	3	1994	354	0.020	Why?
Receptors, CXCR3	1	2006	240	0.010	Why?
Ureter	1	1987	364	0.010	Why?
Lymphocytes	2	1984	2614	0.010	Why?
Hypoglycemic Agents	2	2008	3109	0.010	Why?
Drug Administration Schedule	2	1989	4860	0.010	Why?
Chronic Disease	4	2005	9384	0.010	Why?
Incidence	3	2013	21538	0.010	Why?
Diabetes Mellitus	1	2003	5889	0.010	Why?
Anti-Bacterial Agents	1	2003	7477	0.010	Why?
Binding, Competitive	2	1983	1142	0.010	Why?
Young Adult	3	2016	60066	0.010	Why?
Insulin Resistance	2	2008	3986	0.010	Why?
Mastectomy	2	1965	1861	0.010	Why?
Opportunistic Infections	1	2006	375	0.010	Why?
Fatal Outcome	1	2008	1836	0.010	Why?
L-Selectin	1	2004	212	0.010	Why?
Immunoglobulin Heavy Chains	2	1983	648	0.010	Why?
Postoperative Period	1	1988	1826	0.010	Why?
Biological Therapy	1	2004	140	0.010	Why?
Atrophy	1	2008	1646	0.010	Why?
Receptors, CCR2	1	2004	216	0.010	Why?
Axilla	1	1965	623	0.010	Why?
Kinetics	1	1990	6329	0.010	Why?
Macaca mulatta	1	1989	2363	0.010	Why?
Length of Stay	4	2003	6498	0.010	Why?
Multivariate Analysis	1	2016	12077	0.010	Why?
Mice, Nude	2	1993	3623	0.010	Why?
Peptides	2	2005	4354	0.010	Why?
Mice, Inbred AKR	1	1981	104	0.010	Why?
Recombinant Proteins	1	1992	6514	0.010	Why?
Treatment Failure	1	2008	2661	0.010	Why?
Survival Rate	2	1996	12840	0.010	Why?
Immunoglobulin Variable Region	1	1983	420	0.010	Why?
Cortisone	1	1982	90	0.010	Why?
Infusions, Intravenous	1	2006	2230	0.010	Why?
Adolescent	6	2016	89169	0.010	Why?
Cohort Studies	2	2015	41754	0.010	Why?
Age of Onset	1	2008	3347	0.010	Why?
Socioeconomic Factors	1	2015	7852	0.010	Why?
Cell Fusion	1	1981	294	0.010	Why?
Diabetic Nephropathies	1	1988	973	0.010	Why?
Immune Sera	1	2001	605	0.010	Why?
Rats, Inbred F344	1	1982	826	0.010	Why?
Ribavirin	1	2003	395	0.010	Why?
Injections, Intraperitoneal	1	2001	411	0.010	Why?
Biopsy, Needle	1	2006	1622	0.010	Why?
Immunization, Passive	1	1983	619	0.010	Why?
STAT4 Transcription Factor	1	2000	94	0.010	Why?
Fibrinogen	1	2004	891	0.010	Why?
Hematopoietic Stem Cells	1	1993	3409	0.010	Why?
Whole-Body Irradiation	1	2001	435	0.010	Why?
Glucagon	1	2002	535	0.010	Why?
Probability	1	2006	2479	0.010	Why?
Obesity	1	2003	13090	0.010	Why?
Cell Adhesion	1	2007	3096	0.010	Why?
Databases, Factual	1	2016	8080	0.010	Why?
Antibodies, Viral	1	1992	3216	0.010	Why?
Oligonucleotide Array Sequence Analysis	1	2008	3800	0.010	Why?
Lymphopenia	1	2002	300	0.010	Why?
STAT6 Transcription Factor	1	2000	196	0.010	Why?
Cholesterol	2	2004	2914	0.010	Why?
Rats	4	1996	23760	0.010	Why?
Splenectomy	1	2001	392	0.010	Why?
Transplantation Conditioning	1	2006	1601	0.010	Why?
Gastrectomy	2	1957	693	0.010	Why?
Gene Deletion	1	2007	2675	0.010	Why?
Lymph Node Excision	1	1965	1271	0.010	Why?
Organ Specificity	1	2004	1968	0.010	Why?
Age Factors	2	1994	18412	0.010	Why?
Retreatment	1	2000	598	0.010	Why?
Lymphoproliferative Disorders	1	2002	528	0.010	Why?
ABO Blood-Group System	1	2001	381	0.010	Why?
Reverse Transcriptase Polymerase Chain Reaction	1	2006	4580	0.010	Why?
Reference Values	1	2006	4938	0.010	Why?
Interferon-alpha	1	2003	910	0.010	Why?
Complement System Proteins	1	1981	738	0.010	Why?
Cardiovascular Diseases	1	2004	15662	0.010	Why?
Apoptosis Regulatory Proteins	1	2003	1151	0.010	Why?
Blood Proteins	1	2003	1191	0.010	Why?
Lymphatic Metastasis	1	1965	2914	0.010	Why?
Prednisone	2	1994	1567	0.010	Why?
Analysis of Variance	1	2006	6229	0.010	Why?
Receptors, Antigen, T-Cell	2	2001	2568	0.010	Why?
Constriction	1	1996	168	0.010	Why?
Actuarial Analysis	1	1996	370	0.010	Why?
RNA	1	2006	2720	0.010	Why?
Liver Neoplasms	1	1992	4362	0.010	Why?
Up-Regulation	1	2005	4146	0.010	Why?
Cell Separation	1	2001	1728	0.010	Why?
Phenotype	2	1993	16726	0.010	Why?
Mice, Inbred CBA	1	1996	439	0.010	Why?
Thrombophlebitis	1	1996	289	0.010	Why?
Feasibility Studies	1	2006	5315	0.010	Why?
Disease Models, Animal	2	2006	18349	0.010	Why?
Interferon-gamma	1	2003	3160	0.010	Why?
Cholesterol, LDL	1	2004	2403	0.010	Why?
Medicare	1	1992	6809	0.010	Why?
Monitoring, Immunologic	1	1993	100	0.010	Why?
Vena Cava, Inferior	1	1996	463	0.010	Why?
Pentamidine	1	1992	44	0.010	Why?
H-Y Antigen	1	1992	42	0.010	Why?
Adenoma, Bile Duct	1	1992	29	0.010	Why?
Peptic Ulcer Perforation	1	1952	23	0.010	Why?
Immunohistochemistry	1	2006	11095	0.010	Why?
Chimera	1	1993	454	0.010	Why?
Immunoglobulin Isotypes	1	1992	158	0.010	Why?
Survival	1	1992	160	0.010	Why?
Recurrence	1	2004	8509	0.010	Why?
Glucose	1	2003	4352	0.010	Why?
Biopsy	1	2003	6793	0.010	Why?
Erythrocyte Transfusion	1	1996	575	0.010	Why?
Antibody Specificity	2	1983	1065	0.010	Why?
Pneumonia, Pneumocystis	1	1992	242	0.010	Why?
Trans-Activators	1	2000	2857	0.010	Why?
Sensitivity and Specificity	1	2006	14729	0.010	Why?
Drug Therapy, Combination	2	1992	6316	0.010	Why?
Blood Group Antigens	1	1991	183	0.010	Why?
Aerosols	1	1992	634	0.010	Why?
Immunization	1	1994	1219	0.010	Why?
Quality of Life	1	1991	13490	0.010	Why?
Child, Preschool	1	1992	42669	0.010	Why?
Laparoscopy	1	2001	2041	0.000	Why?
Glomerular Filtration Rate	1	1998	2227	0.000	Why?
Cryptococcus neoformans	1	1989	121	0.000	Why?
Candida	1	1989	173	0.000	Why?
HLA Antigens	1	1994	1334	0.000	Why?
Reproducibility of Results	1	2006	20227	0.000	Why?
Drug Resistance	1	1994	1599	0.000	Why?
Survival Analysis	1	2000	10101	0.000	Why?
Child	2	1994	80917	0.000	Why?
Mice, Inbred DBA	1	1988	624	0.000	Why?
Liver	1	2003	7577	0.000	Why?
Evaluation Studies as Topic	1	1989	1627	0.000	Why?
Isoenzymes	1	1991	1688	0.000	Why?
Renal Dialysis	1	1996	1791	0.000	Why?
Ureteral Calculi	1	1987	111	0.000	Why?
Methylprednisolone	1	1987	386	0.000	Why?
Duodenum	1	1989	495	0.000	Why?
Hepatectomy	1	1989	588	0.000	Why?
Bone Marrow Cells	1	1993	2414	0.000	Why?
Costs and Cost Analysis	1	1990	1667	0.000	Why?
Triglycerides	1	1991	2464	0.000	Why?
Random Allocation	1	1987	2396	0.000	Why?
DNA-Binding Proteins	1	2000	9615	0.000	Why?
Vascular Diseases	1	1991	1162	0.000	Why?
Breast	1	1951	1976	0.000	Why?
Stroke Volume	1	1996	5622	0.000	Why?
Immunoglobulin Light Chains	1	1982	289	0.000	Why?
Fibroblasts	1	1992	4176	0.000	Why?
Cross Reactions	1	1983	828	0.000	Why?
Blood Pressure	1	1996	8543	0.000	Why?
Macromolecular Substances	1	1982	1435	0.000	Why?
Patient Readmission	1	1994	3288	0.000	Why?
Risk	1	1992	9613	0.000	Why?
Neoplasm Recurrence, Local	1	1958	9419	0.000	Why?
Administration, Oral	1	1987	4030	0.000	Why?
Carcinoma, Hepatocellular	1	1992	2333	0.000	Why?
Double-Blind Method	1	1992	12465	0.000	Why?
Dose-Response Relationship, Drug	1	1990	10760	0.000	Why?
Breast Neoplasms	1	1965	21206	0.000	Why?
Longevity	1	1984	1077	0.000	Why?
Brain	1	1982	27360	0.000	Why?
Pilot Projects	1	1988	8741	0.000	Why?
Randomized Controlled Trials as Topic	1	1990	10399	0.000	Why?
Amino Acid Sequence	1	1982	13421	0.000	Why?
Hypertension	1	1990	8616	0.000	Why?

Auchincloss's Networks

Click the

Explore

buttons for more information and interactive visualizations!

Concepts (487)

Explore

Co-Authors (99)

Explore

Similar People (60)

Explore

Same Department

Explore

Physical Neighbors